Cobio Diagnostics Inc

From the company

Cobio Diagnostics is developing a next-generation, phage-amplified diagnostic platform for rapid bacterial identification, antimicrobial susceptibility testing, and minimum inhibitory concentration determination directly from clinical specimens. The approach is phenotypic, instrument-agnostic, and designed to scale across pathogens and healthcare environments. All technologies are currently in pre-commercial development.